EA201171210A1 - Производные оксадиазола - Google Patents

Производные оксадиазола

Info

Publication number
EA201171210A1
EA201171210A1 EA201171210A EA201171210A EA201171210A1 EA 201171210 A1 EA201171210 A1 EA 201171210A1 EA 201171210 A EA201171210 A EA 201171210A EA 201171210 A EA201171210 A EA 201171210A EA 201171210 A1 EA201171210 A1 EA 201171210A1
Authority
EA
Eurasian Patent Office
Prior art keywords
oxadiazol derivatives
compounds
oxadiazol
derivatives
formula
Prior art date
Application number
EA201171210A
Other languages
English (en)
Inventor
Анна Кваттропани
Сирил Монтань
Вольфганг Зауэр
Стефано Крозиньяни
Аньес Бомбрэн
Original Assignee
Мерк Сероно С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Сероно С.А. filed Critical Мерк Сероно С.А.
Publication of EA201171210A1 publication Critical patent/EA201171210A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к соединениям формулы Iв которой R, R, R, R, W, Q и S имеют значения, приведенные в п.1 формулы изобретения. Эти соединения могут быть использованы, например, в лечении аутоиммунных нарушений, таких как рассеянный склероз.
EA201171210A 2009-04-03 2010-03-29 Производные оксадиазола EA201171210A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09157301A EP2241558A1 (en) 2009-04-03 2009-04-03 Oxadiazole derivatives
US16977309P 2009-04-16 2009-04-16
PCT/EP2010/054100 WO2010115751A2 (en) 2009-04-03 2010-03-29 Oxadiazole derivatives

Publications (1)

Publication Number Publication Date
EA201171210A1 true EA201171210A1 (ru) 2012-05-30

Family

ID=40792794

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201171210A EA201171210A1 (ru) 2009-04-03 2010-03-29 Производные оксадиазола
EA201171211A EA020691B1 (ru) 2009-04-03 2010-03-29 Производные оксадиазола

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201171211A EA020691B1 (ru) 2009-04-03 2010-03-29 Производные оксадиазола

Country Status (16)

Country Link
US (2) US8802704B2 (ru)
EP (3) EP2241558A1 (ru)
JP (2) JP5833538B2 (ru)
KR (2) KR20110135987A (ru)
CN (2) CN102803238B (ru)
AR (2) AR076188A1 (ru)
AU (2) AU2010233932B2 (ru)
BR (2) BRPI1015048A2 (ru)
CA (2) CA2755918C (ru)
EA (2) EA201171210A1 (ru)
ES (2) ES2652183T3 (ru)
IL (2) IL215498A (ru)
MX (2) MX2011010451A (ru)
SG (2) SG174449A1 (ru)
WO (2) WO2010112461A1 (ru)
ZA (2) ZA201106854B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2241558A1 (en) * 2009-04-03 2010-10-20 Merck Serono SA Oxadiazole derivatives
TW201206429A (en) * 2010-07-08 2012-02-16 Merck Serono Sa Substituted oxadiazole derivatives
CA2814628C (en) * 2010-10-14 2015-06-16 Daiichi Sankyo Company, Limited Acylbenzene derivative
US9233958B2 (en) 2012-01-18 2016-01-12 Daiichi Sankyo Company, Limited Substituted phenylazole derivatives
US9040711B2 (en) 2012-07-02 2015-05-26 Monsanto Technology Llc Processes for the preparation of 3,5-disubstituted-1,2,4-oxadiazoles
US9540362B2 (en) 2013-02-20 2017-01-10 Lg Life Sciences Ltd. Sphingosine-1-phosphate receptor agonists, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
CN103450171B (zh) * 2013-09-22 2015-07-08 苏州康乃德生物医药有限公司 一种免疫调节化合物、其用途和包含其的药物组合物
CA2990028A1 (en) * 2014-06-26 2015-12-30 Monash University Enzyme interacting agents
AR106530A1 (es) * 2015-10-30 2018-01-24 Ptc Therapeutics Inc Métodos para tratar epilepsia
WO2018187479A1 (en) 2017-04-04 2018-10-11 Case Western Reserve University Method of modulating ribonucleotide reductase
US10676467B2 (en) 2017-06-30 2020-06-09 Washington University Compositions for binding sphingosine-1-phosphate receptor 1 (S1P1), imaging of S1P1, and methods of use thereof
CN107827837B (zh) * 2017-11-21 2021-09-24 苏州朗科生物技术股份有限公司 鞘氨醇-1-磷酸受体调节剂化合物及其制备方法与应用
CN109956912B (zh) * 2017-12-26 2021-10-22 中国医学科学院药物研究所 含二苯基噁二唑的羧酸类化合物、其制备方法及医药用途
CN109761827A (zh) * 2019-02-18 2019-05-17 湖南科瑞生物制药股份有限公司 一种n-苄基乙醇胺的制备方法
CN110987847B (zh) * 2019-12-11 2021-02-19 苏州今蓝纳米科技有限公司 1,3,4-噁二唑衍生物在检测酸以及数据加密和储存中的应用
CN116041277A (zh) * 2023-01-18 2023-05-02 中国药科大学 苯基和联苯基取代的五元杂环类化合物及其制备方法、药物组合物和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4709488B2 (ja) * 2002-01-18 2011-06-22 メルク・シャープ・エンド・ドーム・コーポレイション Ｅｄｇ受容体作動薬としてのＮ−（ベンジル）アミノアルキルカルボン酸化合物、ホスフィン酸化合物、ホスホン酸化合物およびテトラゾール類
CA2547198A1 (en) * 2003-12-17 2005-06-30 Merck & Co., Inc. (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists
CA2610310A1 (en) * 2005-06-08 2006-12-14 Novartis Ag Polycyclic oxadiazoles or isoxazoles and their use as s1p receptor ligands
GB0511684D0 (en) * 2005-06-08 2005-07-13 Novartis Ag Organic compounds
JP2009269819A (ja) * 2006-08-25 2009-11-19 Asahi Kasei Pharma Kk アミン化合物
EP2081916A1 (en) * 2006-09-29 2009-07-29 Novartis AG Oxadiazole derivatives with anti-inflammatory and immunosuppressive properties
JO2701B1 (en) * 2006-12-21 2013-03-03 جلاكسو جروب ليميتد Vehicles
GB0625648D0 (en) * 2006-12-21 2007-01-31 Glaxo Group Ltd Compounds
DK2125797T3 (da) * 2007-03-16 2014-02-10 Actelion Pharmaceuticals Ltd Aminopyridinderivater som s1p1/edg1-receptoragonister
EP2014653A1 (en) * 2007-06-15 2009-01-14 Bioprojet Novel dicarboxylic acid derivatives as S1P1 receptor agonists
EA201070422A1 (ru) * 2007-10-04 2010-12-30 Мерк Сероно С.А. Производные оксадиазола
EP2241558A1 (en) * 2009-04-03 2010-10-20 Merck Serono SA Oxadiazole derivatives

Also Published As

Publication number Publication date
CA2755928A1 (en) 2010-10-07
BRPI1013422A2 (pt) 2016-04-05
ZA201106854B (en) 2012-11-28
IL215498A0 (en) 2011-12-29
AU2010233932A1 (en) 2011-10-13
ES2639028T3 (es) 2017-10-25
IL215497B (en) 2018-12-31
WO2010115751A2 (en) 2010-10-14
ZA201106855B (en) 2012-11-28
US20120022109A1 (en) 2012-01-26
EP2241558A1 (en) 2010-10-20
EP2414342B1 (en) 2017-05-31
CA2755928C (en) 2017-06-20
IL215498A (en) 2017-11-30
BRPI1015048A2 (pt) 2019-09-24
JP5833538B2 (ja) 2015-12-16
CN102803238A (zh) 2012-11-28
JP2012522745A (ja) 2012-09-27
CA2755918C (en) 2018-02-20
SG174449A1 (en) 2011-10-28
ES2652183T3 (es) 2018-01-31
EA020691B1 (ru) 2015-01-30
AU2010230314B2 (en) 2016-07-21
EP2414341A2 (en) 2012-02-08
AR076187A1 (es) 2011-05-26
AU2010233932B2 (en) 2016-10-13
KR20110135987A (ko) 2011-12-20
EA201171211A1 (ru) 2012-05-30
US20120035226A1 (en) 2012-02-09
JP2012522744A (ja) 2012-09-27
AR076188A1 (es) 2011-05-26
US8802704B2 (en) 2014-08-12
JP5833537B2 (ja) 2015-12-16
MX2011010451A (es) 2011-11-18
WO2010115751A3 (en) 2010-12-16
CN102459206A (zh) 2012-05-16
IL215497A0 (en) 2011-12-29
AU2010230314A1 (en) 2011-10-13
SG174448A1 (en) 2011-10-28
MX2011010449A (es) 2011-11-18
KR20120002606A (ko) 2012-01-06
WO2010112461A1 (en) 2010-10-07
EP2414342A1 (en) 2012-02-08
CN102803238B (zh) 2015-09-30
EP2414341B1 (en) 2017-09-13
CA2755918A1 (en) 2010-10-14
US8815919B2 (en) 2014-08-26

Similar Documents

Publication Publication Date Title
EA201171210A1 (ru) Производные оксадиазола
EA201070422A1 (ru) Производные оксадиазола
EA201070423A1 (ru) Диарильные соединения оксадиазолов
EA201070238A1 (ru) Соединения пиримидина
TW201129565A (en) Tricyclic heterocyclic compounds, compositions and methods of use thereof
EA201390877A1 (ru) Замещенные 6,6-конденсированные азотсодержащие гетероциклические соединения и их применение
EA201200119A1 (ru) Гетероциклические соединения в качестве ингибиторов аутотаксина
EA201490357A1 (ru) Индазолы
EA201300282A1 (ru) Производные триазолопиразина
EA201590748A1 (ru) Противовирусные соединения против rsv
EA201100880A1 (ru) Бензонафтиридиновые соединения в качестве ингибиторов аутотаксина
EA201101399A1 (ru) Гетероциклические соединения в качестве ингибиторов аутотаксина
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
EA201070779A1 (ru) Триазолсодержащие производные оксадиазола
EA201291236A1 (ru) Азотные гетероциклические соединения, применимые в качестве ингибиторов pde10
EA201071320A1 (ru) Активаторы глюкокиназы
UA108087C2 (ru) Твердые формы n-(4-(7-азабицикло[2.2.1]гептан-7-ил)-2-(трифторметил)фенил)-4-оксо-5-(трифторметил)-1,4-дигидрохинолин-3-карбоксамида
MX2010003366A (es) Derivados de piperidina y piperazina para el tratamiento de tumores.
EA201200323A1 (ru) Соединения и композиции, как ингибиторы протеинкиназы
MA33939B1 (fr) 5-alcynyl-pyrimidines
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
GEP20146102B (en) Compounds and compositions as protein kinase inhibitors
EA201390609A1 (ru) ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ
MA32811B1 (fr) Nouveaux composés
MX2013004004A (es) Pirrolidinonas como inhibidores de metionina aminopeptidasa (metap-2).